Page 69 - Read Online
P. 69

Dokko et al. Vessel Plus 2022;6:37  https://dx.doi.org/10.20517/2574-1209.2021.121  Page 15 of 21

               Writing the initial abstract/manuscript: Dokko J, Novotny S, Santore LA
               Revising the submitted abstract/manuscript: Dokko J, Novotny S, Santore LA, Shroyer ALW, Bilfinger T
               Reviewing and approving the submitted abstract/manuscript: Dokko J, Novotny S, Santore LA, Shroyer
               ALW, Bilfinger T


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               Not applicable.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2022.


               REFERENCES
               1.       Noubiap JJ, Nyaga UF, Ndoadoumgue AL, Nkeck JR, Ngouo A, Bigna JJ. Meta-analysis of the incidence, prevalence, and correlates
                    of atrial fibrillation in rheumatic heart disease. Glob Heart 2020;15:38.  DOI  PubMed  PMC
               2.       Grigioni F, Benfari G, Vanoverschelde JL, et al; MIDA Investigators. Long-term implications of atrial fibrillation in patients with
                    degenerative mitral regurgitation. J Am Coll Cardiol 2019;73:264-74.  DOI  PubMed
               3.       Eguchi K, Ohtaki E, Matsumura T, et al. Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for
                    degenerative mitral regurgitation. Eur Heart J 2005;26:1866-72.  DOI  PubMed
               4.       Alexiou C, Doukas G, Oc M, et al. The effect of preoperative atrial fibrillation on survival following mitral valve repair for
                    degenerative mitral regurgitation. Eur J Cardiothorac Surg 2007;31:586-91.  DOI  PubMed
               5.       Mehta CK, McCarthy PM, Andrei AC, et al. De novo atrial fibrillation after mitral valve surgery. J Thorac Cardiovasc Surg
                    2018;156:1515-25.e11.  DOI  PubMed
               6.       Bramer S, van Straten AH, Soliman Hamad MA, van den Broek KC, Maessen JG, Berreklouw E. New-onset postoperative atrial
                    fibrillation predicts late mortality after mitral valve surgery. Ann Thorac Surg 2011;92:2091-6.  DOI  PubMed
               7.       Kernis SJ, Nkomo VT, Messika-Zeitoun D, et al. Atrial fibrillation after surgical correction of mitral regurgitation in sinus rhythm:
                    incidence, outcome, and determinants. Circulation 2004;110:2320-5.  DOI  PubMed
               8.       Shen J, Lall S, Zheng V, Buckley P, Damiano RJ Jr, Schuessler RB. The persistent problem of new-onset postoperative atrial
                    fibrillation: a single-institution experience over two decades. J Thorac Cardiovasc Surg 2011;141:559-70.  DOI  PubMed  PMC
               9.       Bowdish ME, D’Agostino RS, Thourani VH, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2020 Update
                    on Outcomes and Research. Ann Thorac Surg 2020;109:1646-55.  DOI  PubMed
               10.       Malavasi VL, Fantecchi E, Tordoni V, et al. Atrial fibrillation pattern and factors affecting the progression to permanent atrial
                    fibrillation. Intern Emerg Med 2021;16:1131-40.  DOI  PubMed
               11.       Boilève V, Dreyfus J, Attias D, et al. Predictors of mitral annulus enlargement? Int J Cardiol 2018;270:349-52.  DOI  PubMed
               12.       Keren G, Etzion T, Sherez J, et al. Atrial fibrillation and atrial enlargement in patients with mitral stenosis. Am Heart J
                    1987;114:1146-55.  DOI  PubMed
               13.       Watanabe N. Acute mitral regurgitation. Heart 2019;105:671-7.  DOI  PubMed
               14.       Harb SC, Griffin BP. Mitral valve disease: a comprehensive review. Curr Cardiol Rep 2017;19:73.  DOI  PubMed
               15.       Diker E, Aydogdu S, Özdemir M, et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J
                    Cardiol 1996;77:96-8.  DOI  PubMed
               16.       Negi PC, Sondhi S, Rana V, et al. Prevalence, risk determinants and consequences of atrial fibrillation in rheumatic heart disease: 6
                    years hospital based-Himachal Pradesh- Rheumatic Fever/Rheumatic Heart Disease (HP-RF/RHD) Registry. Indian Heart J 2018;70
                    Suppl 3:S68-73.  DOI  PubMed  PMC
   64   65   66   67   68   69   70   71   72   73   74